{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:12:44Z","timestamp":1777979564960,"version":"3.51.4"},"reference-count":0,"publisher":"International Institute of Anticancer Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDP"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>Background\/Aim: \nPrompt treatment in acute promyelocytic leukemia (APML) is critical due to high risk of early mortality. Early initiation of chemotherapy has been associated with favorable outcomes. The purpose of this study was to investigate differences in inpatient outcomes of APML based on time to chemotherapy initiation.\nPatients and Methods: \nThe National Inpatient Sample (NIS) was queried between the years 2016 and 2020 to identify all patients with APML who were administered chemotherapy inpatient. These patients were stratified into an early cohort if chemotherapy was given within 24 hours of admission and late cohort if it was after 24 hours. Baseline characteristics were compared amongst cohorts using independent sample t-tests and Chi-squared tests.\nResults: \nAmong 5,155 APML patients, 1,300 (25.2%) received early treatment and 3,855 (74.8%) late. Early treated patients were younger (45.4\u00b119.4 vs. 47.6\u00b118.9 years; p&lt;001) with comparable sex distribution (50.8% vs. 48.0% female; p=0.083). Racial distribution was similar but statistically different due to sample size: White (58.9% vs. 58.7%) and Black (13.3% vs. 12.6%) (p&lt;0.001). Early treated patients had lower Charlson Comorbidity Index (CCI) scores (3.9 vs. 4.2; p&lt;0.001), shorter hospital stays (18.0 vs. 29.5 days; p&lt;0.001), lower hospital charges ($262,436 vs. $405,537; p&lt;0.001), lower rates of neutropenia (14.2% vs. 21.8%), sepsis (9.6% vs. 14.3%), disseminated intravascular coagulation (DIC) (23.8% vs. 35.8%), and mortality (4.6% vs. 6.7%) (p&lt;0.01 for all).\nConclusion: \nEarly chemotherapy was associated with lower rates of DIC, sepsis and mortality despite similar demographics and comorbidity burden in APML patients. These findings support immediate initiation of chemotherapy upon presentation.<\/jats:p>","DOI":"10.21873\/cdp.10539","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:32:03Z","timestamp":1777977123000},"page":"399-407","source":"Crossref","is-referenced-by-count":0,"title":["Association of Early Chemotherapy With Reduced In-Hospital Mortality and Complications in Acute Promyelocytic Leukemia: Insights From a Nationwide Cohort"],"prefix":"10.21873","volume":"6","author":[{"given":"FIQE","family":"KHAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ABDULLAH","family":"AHMAD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MEHER","family":"AYYAZUDDIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SANTOSH","family":"NALLURI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SURIYA","family":"BASKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"9336","published-online":{"date-parts":[[2026,5,1]]},"container-title":["Cancer Diagnosis &amp; Prognosis"],"original-title":[],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:32:03Z","timestamp":1777977123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cancerdiagnosisprognosis.org\/article\/601\/association-of-early-chemotherapy-with-reduced-in-hospital-mortality-and-complications-in-acute-promyelocytic-leukemia-insights-from-a-nationwide-cohort"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,5,1]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.21873\/cdp.10539","relation":{},"ISSN":["2732-7787"],"issn-type":[{"value":"2732-7787","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}